Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute

Launched by ASSIUT UNIVERSITY · Oct 7, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how common acute kidney injury (AKI) is among children with cancer at the South Egypt Cancer Institute. AKI is a sudden loss of kidney function that can happen during cancer treatment, and if not managed properly, it can lead to serious issues. The researchers want to find out how often this happens in young patients who are being treated for different types of cancers, including blood cancers and solid tumors.

To participate in this study, children must be between 1 month and 18 years old and have a confirmed cancer diagnosis. Unfortunately, children who already have long-term kidney problems or who are older than 18 at the time of diagnosis won't be eligible. While the trial is not yet recruiting participants, those who join will help researchers learn more about the risks of kidney injury in pediatric cancer patients, which could lead to better care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Children of both sexes (aged from 1 month to 18 years at diagnosis)
• • Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department
• Exclusion Criteria:
• • Children who had an unconfirmed cancer diagnosis.
• • Children more than 18 years at diagnosis.
• • Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month
• • The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level.
• • Patient underwent renal transplant.